Rimostil has been developed specifically to maintain bone and cholesterol health, and also to promote health and well-being in women after menopause. After menopause the body produces fewer hormones. Rimostil has been designed for women at this stage, to maintain their health and vitality. To enjoy their busy middle years, women require healthy bones and a healthy heart. Rimostil is a natural dietary supplement containing 57 mg of a proprietary ratio of four important isoflavones for the maintenance of good health. The isoflavones in Rimostil have been extracted from red clover (Trifolium pratense). Novogen Research has developed Rimostil following clinical trials, specifically to meet the needs of women after menopause.